Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag -specific immune responses

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Van Gulck, Ellen ^a   Cools, Nathalie ^b   Atkinson, Derek ^a   Bracke, Lotte ^a   Vereecken, Katleen ^a   Vekemans, Marc ^a   Van Tendeloo, Viggo F I ^b,c   Berneman, Zwi N ^b,c   Vanham, Guido ^a,d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTERLEUKIN 12P70; GAMMA INTERFERON; IMIDAZOLE DERIVATIVE; INTERLEUKIN 12; MESSENGER RNA; RESIQUIMOD;

ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS IMMUNITY; ANTIGEN PRESENTATION; ELECTROPORATION; GENE TRANSFER; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ELECTROPORATION; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE TRANSFER TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; IMIDAZOLES; INTERFERON-GAMMA; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; RNA, MESSENGER;

EID: 84864953127     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/184979     Document Type: Article

References (76)

1. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome Journal of Virology 1994 68 7 4650 4655 (Pubitemid 24183063)
2. Borrow P., Lewicki H., Hahn B. H., Shaw G. M., Oldstone M. B. A., Virus-specific CD8 + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection Journal of Virology 1994 68 9 6103 6110 (Pubitemid 24258634)
3. Migueles S. A., Laborico A. C., Shupert W. L., Sabbaghian M. S., Rabin R., Hallahan C. W., Van Baarle D., Kostense S., Miedema F., McLaughlin M., Ehler L., Metcalf J., Liu S., Connors M., HIV-specific CD8 + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors Nature Immunology 2002 3 11 1061 1068 (Pubitemid 35363659)
4. Hess C., Altfeld M., Thomas S. Y., Addo M. M., Rosenberg E. S., Allen T. M., Draenert R., Eldrige R. L., Van Lunzen J., Stellbrink H. J., Walker B. D., Luster A. D., HIV-1 specific CD8 + T cells with an effector phenotype and control of viral replication The Lancet 2004 363 9412 863 866 (Pubitemid 38368837)
5. Pantaleo G., Koup R. A., Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know Nature Medicine 2004 10 8 806 810 (Pubitemid 39070851)
6. Benito J. M., Lpez M., Soriano V., The role of CD8 + T-cell response in HIV infection AIDS Reviews 2004 6 2 79 88 (Pubitemid 39149446)
7. Betts M. R., Ambrozak D. R., Douek D. C., Bonhoeffer S., Brenchley J. M., Casazza J. P., Koup R. A., Picker L. J., Analysis of total human immunodeficiency virus (HIV)-specific CD4 + and CD8 + T-cell responses: relationship to viral load in untreated HIV infection Journal of Virology 2001 75 24 11983 11991 (Pubitemid 33115870)
8. Lpez M., Soriano V., Ralln N., Cascajero A., Gonzlez-Lahoz J., Benito J. M., Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8 + T cells European Journal of Immunology 2008 38 6 1548 1558
9. Migueles S. A., Weeks K. A., Nou E., Berkley A. M., Rood J. E., Osborne C. M., Hallahan C. W., Cogliano-Shutta N. A., Metcalf J. A., McLaughlin M., Kwan R., Mican J. M., Davey R. T., Connors M., Defective human immunodeficiency virus-specific CD8 + T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy Journal of Virology 2009 83 22 11876 11889
10. Douek D. C., Kwong P. D., Nabel G. J., The rational design of an AIDS vaccine Cell 2006 124 4 677 681 (Pubitemid 43261441)
11. Autran B., Murphy R. L., Costagliola D., Tubiana R., Clotet B., Gatell J., Staszewski S., Wincker N., Assoumou L., El-Habib R., Calvez V., Walker B., Katlama C., Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) AIDS 2008 22 11 1313 1322
12. Papagno L., Alter G., Assoumou L., Murphy R. L., Garcia F., Clotet B., Larsen M., Braibant M., Marcelin A. G., Costagliola D., Altfeld M., Katlama C., Autran B., Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine AIDS 2011 25 1 27 36
13. Cools N., Ponsaerts P., Van Tendeloo V. F. I., Berneman Z. N., Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells Journal of Leukocyte Biology 2007 82 6 1365 1374 (Pubitemid 350276946)
14. Cools N., Petrizzo A., Smits E., Buonaguro F. M., Tornesello M. L., Berneman Z., Buonaguro L., Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? Immunotherapy 2011 3 10 1203 1222
15. Gilboa E., DC-based cancer vaccines The Journal of Clinical Investigation 2007 117 5 1195 1203 (Pubitemid 46718404)
16. Van Gulck E. R. A., Ponsaerts P., Heyndrickx L., Vereecken K., Moerman F., De Roo A., Colebunders R., Van Den Bosch G., Van Bockstaele D. R., Van Tendeloo V. F. I., Allard S., Verrier B., Maran C., Hoeffel G., Hosmalin A., Berneman Z. N., Vanham G., Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 gag and Env proteins Blood 2006 107 5 1818 1827 (Pubitemid 43289359)
17. Van Gulck E. R., Vanham G., Heyndrickx L., Coppens S., Vereecken K., Atkinson D., Florence E., Kint I., Berneman Z. N., Van Tendeloo V., Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals Journal of Virology 2008 82 7 3561 3573 (Pubitemid 351429932)
18. Van Tendeloo V. F. I., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., Van Bockstaele D. R., Berneman Z. N., Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 2001 98 1 49 56
19. Boczkowski D., Nair S. K., Snyder D., Gilboa E., Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo Journal of Experimental Medicine 1996 184 2 465 472 (Pubitemid 26324100)
20. Chassin D., Andrieu M., Cohen W., Culmann-Penciolelli B., Ostankovitch M., Hanau D., Guillet J.-G., Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects European Journal of Immunology 1999 29 1 196 202 (Pubitemid 29043537)
21. Geldmacher C., Gray C., Nason M., Currier J. R., Haule A., Njovu L., Geis S., Hoffmann O., Maboko L., Meyerhans A., Cox J., Hoelscher M., A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection Journal of Virology 2007 81 24 13809 13815 (Pubitemid 350247874)
22. Kavanagh D. G., Kaufmann D. E., Sunderji S., Frahm N., Le Gall S., Boczkowski D., Rosenberg E. S., Stone D. R., Johnston M. N., Wagner B. S., Zaman M. T., Brander C., Gilboa E., Walker B. D., Bhardwaj N., Expansion of HIV-specific CD4 + and CD8 + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef Blood 2006 107 5 1963 1969 (Pubitemid 43289378)
23. Melhem N. M., Liu X. D., Boczkowski D., Gilboa E., Barratt-Boyes S. M., Robust CD4 + and CD8 + T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag European Journal of Immunology 2007 37 8 2164 2173 (Pubitemid 47250209)
24. Sbe-Larssen S., Fossberg E., Gaudernack G., mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT) Journal of Immunological Methods 2002 259 1-2 191 203 (Pubitemid 33124396)
25. Strobel I., Berchtold S., Gtze A., Schulze U., Schuler G., Steinkasserer A., Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes Gene Therapy 2000 7 23 2028 2035 (Pubitemid 32036769)
26. Jonuleit H., Khn U., Mller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions European Journal of Immunology 1997 27 12 3135 3142 (Pubitemid 28018007)
27. Van Driessche A., Van De Velde A. L. R., Nijs G., Braeckman T., Stein B., De Vries J. M., Berneman Z. N., Van Tendeloo V. F. I., Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase i dose-escalation clinical trial Cytotherapy 2009 11 5 653 668
28. Markovic S. N., Dietz A. B., Greiner C. W., Maas M. L., Butler G. W., Padley D. J., Bulur P. A., Allred J. B., Creagan E. T., Ingle J. N., Gastineau D. A., Vuk-Pavlovic S., Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma Journal of Translational Medicine 2006 4, article 35
29. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K. A., Maliszewski C., Shortman K., Cebon J., Maraskovsky E., Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E 2 regulates the migratory capacity of specific DC subsets Blood 2002 100 4 1362 1372 (Pubitemid 34864293)
30. Felzmann T., Httner K. G., Breuer S. K., Wimmer D., Ressmann G., Wagner D., Paul P., Lehner M., Heitger A., Holter W., Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses Cancer Immunology, Immunotherapy 2005 54 8 769 780 (Pubitemid 40977145)
31. Httner K. G., Breuer S. K., Paul P., Majdic O., Heitger A., Felzmann T., Generation of potent anti-tumor immunity in mice by interleukin-12- secreting dendritic cells Cancer Immunology, Immunotherapy 2005 54 1 67 77 (Pubitemid 40064487)
32. Bontkes H. J., Kramer D., Ruizendaal J. J., Kueter E. W. M., van Tendeloo V. F. I., Meijer C. J. L. M., Hooijberg E., Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells Gene Therapy 2007 14 4 366 375 (Pubitemid 46231930)
33. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F., Kinetics of dendritic cell activation: impact on priming of TH1,TH2 and nonpolarized T cells Nature Immunology 2000 1 4 311 316
34. Reis e Sousa C., Yap G., Schulz O., Rogers N., Schito M., Aliberti J., Hieny S., Sher A., Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology Immunity 1999 11 5 637 647
35. Kaliski P., Schuitemaker J. H. N., Hilkens C. M. U., Wierenga E. A., Kapsenberg M. L., Final maturation of dendritic cells is associated with impaired responsiveness to IFN- and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells Journal of Immunology 1999 162 6 3231 3236 (Pubitemid 29313569)
36. Vieira P. L., De Jong E. C., Wierenga E. A., Kapsenberg M. L., Kaliski P., Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction Journal of Immunology 2000 164 9 4507 4512 (Pubitemid 30238046)
37. Boullart A. C. I., Aarntzen E. H. J. G., Verdijk P., Jacobs J. F. M., Schuurhuis D. H., Benitez-Ribas D., Schreibelt G., Van De Rakt M. W. M. M., Scharenborg N. M., De Boer A., Kramer M., Figdor C. G., Punt C. J. A., Adema G. J., De Vries I. J. M., Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E 2 results in high interleukin-12 production and cell migration Cancer Immunology, Immunotherapy 2008 57 11 1589 1597
38. Bojak A., Wild J., Deml L., Wagner R., Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag -specific DNA vaccines Intervirology 2002 45 46 275 286 (Pubitemid 36173436)
39. Romani N., Gruner S., Brang D., Kmpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G., Proliferating dendritic cell progenitors in human blood Journal of Experimental Medicine 1994 180 1 83 93 (Pubitemid 24181058)
40. Ponsaerts P., Van Tendeloo V. F. I., Cools N., Van Driessche A., Lardon F., Nijs G., Lenjou M., Mertens G., Van Broeckhoven C., Van Bockstaele D. R., Berneman Z. N., mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation Leukemia 2002 16 7 1324 1330
41. Janetzki S., Panageas K. S., Ben-Porat L., Boyer J., Britten C. M., Clay T. M., Kalos M., Maecker H. T., Romero P., Yuan J., Martin Kast W., Hoos A., Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) Cancer Immunology, Immunotherapy 2008 57 3 303 315 (Pubitemid 350295382)
42. Moodie Z., Price L., Janetzki S., Britten C. M., Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories Methods in Molecular Biology 2012 792 185 196
43. Lu W., Arraes L. C., Ferreira W. T., Andrieu J. M., Therapeutic dendritic-cell vaccine for chronic HIV-1 infection Nature Medicine 2004 10 12 1359 1365 (Pubitemid 40022718)
44. Lu W., Wu X., Lu Y., Guo W., Andrieu J. M., Therapeutic dendritic-cell vaccine for simian aids Nature Medicine 2003 9 1 27 32 (Pubitemid 36098256)
45. Kundu S. K., Dupuis M., Sette A., Celis E., Dorner F., Eibl M., Merigan T. C., Role of preimmunization virus sequences in cellular immunity in HIV- infected patients during HIV type 1 MN recombinant gp160 immunization AIDS Research and Human Retroviruses 1998 14 18 1669 1678 (Pubitemid 28563858)
46. Garca F., Lejeune M., Climent N., Gil C., Alcam J., Morente V., Als L., Ruiz A., Setoain J., Fumero E., Castro P., Lpez A., Cruceta A., Piera C., Florence E., Pereira A., Libois A., Gonzlez N., Guil M., Caballero M., Lomea F., Joseph J., Mir J. M., Pumarola T., Plana M., Gatell J. M., Gallart T., Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection Journal of Infectious Diseases 2005 191 10 1680 1685 (Pubitemid 40656756)
47. Garca F., Climent N., Assoumou L., Gil C., Gonzlez N., Alcam J., Len A., Romeu J., Dalmau J., Martnez-Picado J., Lifson J., Autran B., Costagliola D., Clotet B., Gatell J. M., Plana M., Gallart T., A therapeutic dendritic cell-based vaccine for HIV-1 infection Journal of Infectious Diseases 2011 203 4 473 478
48. Ide F., Nakamura T., Tomizawa M., Kawana-Tachikawa A., Odawara T., Hosoya N., Iwamoto A., Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial Journal of Medical Virology 2006 78 6 711 718
49. Connolly N. C., Whiteside T. L., Wilson C., Kondragunta V., Rinaldo C. R., Riddler S. A., Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals Clinical and Vaccine Immunology 2008 15 2 284 292 (Pubitemid 352025534)
50. Gandhi R. T., O'Neill D., Bosch R. J., Chan E. S., Bucy R. P., Shopis J., Baglyos L., Adams E., Fox L., Purdue L., Marshak A., Flynn T., Masih R., Schock B., Mildvan D., Schlesinger S. J., Marovich M. A., Bhardwaj N., Jacobson J. M., A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy Vaccine 2009 27 43 6088 6094
51. Kloverpris H., Karlsson I., Bonde J., Thorn M., Vinner L., Pedersen A. E., Hentze J. L., Andresen B. S., Svane I. M., Gerstoft J., Kronborg G., Fomsgaard A., Induction of novel CD8 + T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes AIDS 2009 23 11 1329 1340
52. Routy J. P., Boulassel M. R., Yassine-Diab B., Nicolette C., Healey D., Jain R., Landry C., Yegorov O., Tcherepanova I., Monesmith T., Finke L., Sékaly R. P., Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy Clinical Immunology 2010 134 2 140 147
53. Kaliski P., Hilkens C. M. U., Wierenga E. A., Kapsenberg M. L., T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal Immunology Today 1999 20 12 561 567
54. Van Kooten G., Banchereau J., CD40-CD40 ligand Journal of Leukocyte Biology 2000 67 1 2 17 (Pubitemid 30046812)
55. Croft M., Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nature Reviews Immunology 2003 3 8 609 620 (Pubitemid 37328664)
56. Lenschow D. J., Walunas T. L., Bluestone J. A., CD28/B7 system of T cell costimulation Annual Review of Immunology 1996 14 233 258 (Pubitemid 26130184)
57. Trinchieri G., Pflanz S., Kastelein R. A., The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses Immunity 2003 19 5 641 644 (Pubitemid 37490789)
58. Zobywalski A., Javorovic M., Frankenberger B., Pohla H., Kremmer E., Bigalke I., Schendel D. J., Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70 Journal of Translational Medicine 2007 5, article 18
59. Palmer B. E., Boritz E., Blyveis N., Wilson C. C., Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4 + T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication Journal of Virology 2002 76 12 5925 5936 (Pubitemid 34556287)
60. Van Gulck E., Vlieghe E., Vekemans M., Van Tendeloo V. F. I., Van De Velde A., Smits E., Anguille S., Cools N., Goossens H., Mertens L., De Haes W., Wong J., Florence E., Vanham G., Berneman Z. N., MRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients AIDS 2012 26 4 F1 F12
61. Soares H., Waechter H., Glaichenhaus N., Mougneau E., Yagita H., Mizenina O., Dudziak D., Nussenzweig M. C., Steinman R. M., A subset of dendritic cells induces CD4 + T cells to produce IFN- by an IL-12-independent but CD70-dependent mechanism in vivo Journal of Experimental Medicine 2007 204 5 1095 1106 (Pubitemid 46798153)
62. Zimmerli S. C., Harari A., Cellerai C., Vallelian F., Bart P. A., Pantaleo G., HIV-1-specific IFN- /IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7239 7244 (Pubitemid 40696363)
63. Lichterfeld M., Yu X. G., Waring M. T., Mui S. K., Johnston M. N., Cohen D., Addo M. M., Zaunders J., Alter G., Pae E., Strick D., Allen T. M., Rosenberg E. S., Walker B. D., Altfeld M., HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8 + T cells producing both interferon- and tumor necrosis factor- Blood 2004 104 2 487 494 (Pubitemid 38900032)
64. Betts M. R., Gray C. M., Cox J. H., Ferrari G., Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development Expert Review of Vaccines 2006 5 4 505 516 (Pubitemid 44627882)
65. Dubois B., Massacrier C., Vanbervliet B., Fayette J., Brire F., Banchereau J., Caux C., Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes Journal of Immunology 1998 161 5 2223 2231 (Pubitemid 28397033)
66. Schmitt N., Morita R., Bourdery L., Bentebibel S. E., Zurawski S. M., Banchereau J., Ueno H., Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12 Immunity 2009 31 1 158 169
67. Banchereau J., Klechevsky E., Schmitt N., Morita R., Palucka K., Ueno H., Harnessing human dendritic cell subsets to design novel vaccines Annals of the New York Academy of Sciences 2009 1174 24 32
68. Chehimi J., Paganin C., Frank I., Chouaib S., Starr S., Trinchieri G., Interleukin-12 in the pathogenesis and therapy of HIV disease Research in Immunology 1995 146 7-8 605 614 (Pubitemid 26054858)
69. Hirao L. A., Wu L., Khan A. S., Hokey D. A., Yan J., Dai A., Betts M. R., Draghia-Akli R., Weiner D. B., Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques Vaccine 2008 26 25 3112 3120
70. Schadeck E. B., Sidhu M., Egan M. A., Chong S. Y., Piacente P., Masood A., Garcia-Hand D., Cappello S., Roopchand V., Megati S., Quiroz J., Boyer J. D., Felber B. K., Pavlakis G. N., Weiner D. B., Eldridge J. H., Israel Z. R., A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIV gag -plasmid DNA vaccine in rhesus macaques Vaccine 2006 24 21 4677 4687 (Pubitemid 43776758)
71. Van Der Meide P. H., Villinger F., Ansari A. A., Groenestein R. J., De Labie M. C. D. C., Van Den Hout Y. J. M., Koornstra W. H., Bogers W. M. J. M., Heeney J. L., Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques Vaccine 2002 20 17-18 2296 2302 (Pubitemid 34497040)
72. Traxlmayr M. W., Wesch D., Dohnal A. M., Funovics P., Fischer M. B., Kabelitz D., Felzmann T., Immune suppression by t-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells Journal of Immunotherapy 2010 33 1 40 52
73. Banatvala J., Van Damme P., Oehen S., Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory Vaccine 2000 19 7-8 877 885
74. Allen T. M., Vogel T. U., Fuller D. H., Mothé B. R., Steffen S., Boyson J. E., Shipley T., Fuller J., Hanke T., Sette A., Altman J. D., Moss B., McMichael A. J., Watkins D. I., Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen Journal of Immunology 2000 164 9 4968 4978 (Pubitemid 30238103)
75. Amara R. R., Villinger F., Altman J. D., Lydy S. L., O'Neil S. P., Staprans S. I., Montefiori D. C., Xu Y., Herndon J. G., Wyatt L. S., Candido M. A., Kozyr N. L., Earl P. L., Smith J. M., Ma H. L., Grimm B. D., Hulsey M. L., Miller J., McClure H. M., McNicholl J. M., Moss B., Robinson H. L., Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 2001 292 5514 69 74 (Pubitemid 32289126)
76. Hanke T., McMichael A., Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS Immunology Letters 1999 66 13 177 181 (Pubitemid 29136836)